121 related articles for article (PubMed ID: 313937)
1. Conversion of high molecular weight human epidermal growth factor (hEGF)/urogastrone (UG) to small molecular weight hEGF/UG by mouse EGF-associated arginine esterase.
Hirata Y; Orth DN
J Clin Endocrinol Metab; 1979 Sep; 49(3):481-3. PubMed ID: 313937
[TBL] [Abstract][Full Text] [Related]
2. Human plasma epidermal growth factor/beta-urogastrone is associated with blood platelets.
Oka Y; Orth DN
J Clin Invest; 1983 Jul; 72(1):249-59. PubMed ID: 6603475
[TBL] [Abstract][Full Text] [Related]
3. Human brain tumor-associated urinary high molecular weight transforming growth factor: a high molecular weight form of epidermal growth factor.
Stromberg K; Hudgins WR; Dorman LS; Henderson LE; Sowder RC; Sherrell BJ; Mount CD; Orth DN
Cancer Res; 1987 Feb; 47(4):1190-6. PubMed ID: 3026622
[TBL] [Abstract][Full Text] [Related]
4. Epidermal growth factor (urogastrone) in human tissues.
Hirata Y; Orth DN
J Clin Endocrinol Metab; 1979 Apr; 48(4):667-72. PubMed ID: 219006
[TBL] [Abstract][Full Text] [Related]
5. Assessment by a two-site enzyme immunoassay of human epidermal growth factor (urogastrone) in the urine of patients with various gastrointestinal diseases including malignant tumors.
Kurobe M; Aono M; Moriga M; Furukawa S; Hayashi K
Biochem Int; 1985 Dec; 11(6):817-23. PubMed ID: 3937528
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies specific for high molecular weight form of human epidermal growth factor.
Koga J; Nishimuro S; Shirono H; Ito C; Yamamoto Y; Matsuo A; Kurobe M; Hayashi K
Biochem Int; 1989 Aug; 19(2):445-52. PubMed ID: 2818606
[TBL] [Abstract][Full Text] [Related]
7. Homologous radioimmunoassay for human epidermal growth factor (urogastrone).
Dailey GE; Kraus JW; Orth DN
J Clin Endocrinol Metab; 1978 Jun; 46(6):929-36. PubMed ID: 318106
[TBL] [Abstract][Full Text] [Related]
8. Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.
Stromberg K; Hudgins WR
Cancer Res; 1986 Nov; 46(11):6004-10. PubMed ID: 3019543
[TBL] [Abstract][Full Text] [Related]
9. Immunoreactive human epidermal growth factor in human pancreatic juice.
Hirata Y; Uchihashi M; Nakajima M; Fujita T; Matsukura S
J Clin Endocrinol Metab; 1982 Jun; 54(6):1242-5. PubMed ID: 6978887
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and secretion of an hEGF-like immunoreactive factor by human gastric cancer cells (MKN-45).
Mori K; Ibaragi S; Kurobe M; Furukawa S; Hayashi K
Biochem Int; 1987 May; 14(5):779-85. PubMed ID: 3502641
[TBL] [Abstract][Full Text] [Related]
11. The identification of urogastrone in serum, saliva, and gastric juice.
Gregory H; Walsh S; Hopkins CR
Gastroenterology; 1979 Aug; 77(2):313-8. PubMed ID: 312747
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of epidermal growth factor (beta-urogastrone) and epidermal growth factor fragments from large volumes of human urine.
Mount CD; Lukas TJ; Orth DN
Arch Biochem Biophys; 1985 Jul; 240(1):33-42. PubMed ID: 3874599
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and secretion of an epidermal growth factor (EGF) by human fibroblast cells in culture.
Kurobe M; Furukawa S; Hayashi K
Biochem Biophys Res Commun; 1985 Sep; 131(3):1080-5. PubMed ID: 3902018
[TBL] [Abstract][Full Text] [Related]
14. Some properties of human epidermal growth factor (hEGF)-like immunoreactive material originating from platelets during blood coagulation.
Kurobe M; Tokida N; Furukawa S; Hayashi K
Biochem Int; 1986 Nov; 13(5):729-33. PubMed ID: 3545207
[TBL] [Abstract][Full Text] [Related]
15. Direct stimulation of bone resorption by epidermal growth factor.
Raisz LG; Simmons HA; Sandberg AL; Canalis E
Endocrinology; 1980 Jul; 107(1):270-3. PubMed ID: 6966568
[TBL] [Abstract][Full Text] [Related]
16. Detection of epidermal growth factor-urogastrone and its receptor during fetal mouse development.
Nexø E; Hollenberg MD; Figueroa A; Pratt RM
Proc Natl Acad Sci U S A; 1980 May; 77(5):2782-5. PubMed ID: 6248866
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a high-molecular-weight form of epidermal growth factor in an extract of human urine.
Mount CD; Lukas TJ; Orth DN
Arch Biochem Biophys; 1987 May; 255(1):1-7. PubMed ID: 3496043
[TBL] [Abstract][Full Text] [Related]
18. Critical functional requirement for the guanidinium group of the arginine 41 side chain of human epidermal growth factor as revealed by mutagenic inactivation and chemical reactivation.
Engler DA; Campion SR; Hauser MR; Cook JS; Niyogi SK
J Biol Chem; 1992 Feb; 267(4):2274-81. PubMed ID: 1733935
[TBL] [Abstract][Full Text] [Related]
19. Human epidermal growth factor in gastric carcinoma as a biologic marker of high malignancy.
Tahara E; Sumiyoshi H; Hata J; Yasui W; Taniyama K; Hayashi T; Nagae S; Sakamoto S
Jpn J Cancer Res; 1986 Feb; 77(2):145-52. PubMed ID: 2420773
[TBL] [Abstract][Full Text] [Related]
20. Molecular nature of human epidermal growth factor (hEGF)-like immunoreactivity in human plasma.
Kurobe M; Furukawa S; Hayashi K
Biochem Int; 1986 May; 12(5):677-83. PubMed ID: 3524570
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
